Table 3.
Postmortem human AD and age matched unaffected control patient sample information.
| Patient ID | Fluid | Disorder | Age (years) | Sex |
|---|---|---|---|---|
| EOAD samples (<65 years) | ||||
| 7626 | CSF & Serum | Unaffected control | 57 | Male |
| 13872 | CSF & Serum | Unaffected control | 57 | Male |
| 12772 | CSF & Serum | Alzheimer's disease | 52 | Male |
| 13373 | CSF & Serum | Alzheimer's disease | 59 | Male |
| 5854 | CSF | Alzheimer disease | 56 | Female |
| 5955 | CSF | Alzheimer disease; amyotrophic lateral sclerosis | 58 | Male |
| 6143 | CSF | Alzheimer disease; schizophrenia | 59 | Female |
| 5985 | CSF | Unaffected control | 55 | Male |
| 6051 | CSF | Unaffected control | 52 | Male |
| LOAD samples (>65 years) | ||||
| 5824 | CSF & Serum | Unaffected control | 74 | Male |
| 5963 | CSF & Serum | Alzheimer disease | 76 | Male |
| 6010 | CSF & Serum | Alzheimer disease | 78 | Female |
| 6078 | CSF & Serum | Alzheimer disease | 74 | Male |